Arcataur Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Buy |
1,038
+37
| +4% | +$19.4K | 0.17% | 57 |
|
|
2025
Q1 | $635K | Sell |
1,001
-52
| -5% | -$33K | 0.22% | 45 |
|
|
2024
Q4 | $750K | Buy |
1,053
+267
| +34% | +$190K | 0.25% | 41 |
|
|
2024
Q3 | $826K | Sell |
786
-10
| -1% | -$10.5K | 0.28% | 39 |
|
|
2024
Q2 | $837K | Sell |
796
-4
| -0.5% | -$4.2K | 0.3% | 37 |
|
|
2024
Q1 | $770K | Hold |
800
| – | – | 0.28% | 38 |
|
|
2023
Q4 | $703K | Hold |
800
| – | – | 0.27% | 36 |
|
|
2023
Q3 | $658K | Hold |
800
| – | – | 0.28% | 36 |
|
|
2023
Q2 | $575K | Buy |
+800
| New | +$575K | 0.24% | 41 |
|